Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

KV Pharmaceutical

This article was originally published in The Tan Sheet

Executive Summary

Former Boehringer Mannheim President Ted Wood joins as president and CEO of St. Louis-based KV. Wood succeeds Mark Hermelin as CEO, while Hermelin retains his vice chair post. Wood previously spent 15 years at Beecham Labs and served as its president when it merged with SmithKline in 1989. While at Beecham, sales grew from $24 mil. to over $500 mil. Wood had been president at Boehringer Mannheim since January 1992
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082457

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel